⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL482881 | 0.72 | — | — | |
| SCHEMBL1277451 | 0.67 | — | — | |
| SCHEMBL31555692 | 0.67 | — | — | |
| SCHEMBL29245 | 0.63 | — | — | |
| SCHEMBL13697668 | 0.63 | — | — | |
| Charcoal, Activated SCHEMBL7169533 | 0.59 | — | — | |
| SCHEMBL10579749 | 0.58 | — | — | |
| Ammonia Solution, Strong SCHEMBL9615643 | 0.58 | — | — | |
| SCHEMBL31413506 | 0.58 | — | — | |
| SCHEMBL7524249 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1263762-A4 | ANTI-INFECTIVE ECTATM | NEWBIOTICS INC (US) | 2003-04-02 | — | — | EP | claimed |
| EP-1263762-A1 | ANTI-INFECTIVE ECTATM | Newbiotics Inc. (US) | 2002-12-11 | — | — | EP | claimed |
| WO-2001064687-A1 | ANTI-INFECTIVE ECTA?TM¿ | NEWBIOTICS, INC. (US) | 2001-09-07 | — | — | WO | claimed |
| EP-1263762-A4 | ANTI-INFECTIVE ECTATM | NEWBIOTICS INC (US) | 2003-04-02 | — | — | EP | disclosed |
| EP-1263762-A1 | ANTI-INFECTIVE ECTATM | Newbiotics Inc. (US) | 2002-12-11 | — | — | EP | disclosed |
| WO-2001064687-A1 | ANTI-INFECTIVE ECTA?TM¿ | NEWBIOTICS, INC. (US) | 2001-09-07 | — | — | WO | disclosed |